Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol, Codeine, and Caffeine for Post-Traumatic Pain
NCT05229965Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Nov 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of codeine, caffeine in psychological trauma, sponsored by Université de Monastir. Started Nov 2022; status: completed.
02
Drugs
codeinecaffeine
03
Conditions
psychological trauma
Beyond the preview
Go deeper on NCT05229965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229965.